allogenic thymocyte-depleted thymus tissue-agdc
allogenic thymocyte-depleted thymus tissue-agdc is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including RETHYMIC. Available dosage form: implant.
Drug Details
- Generic Name
- allogenic thymocyte-depleted thymus tissue-agdc
- Brand Names
- RETHYMIC
- Application Number
- BLA125685
- Sponsor
- Sumitomo Pharma America, Inc.
- NDC Codes
- 1
- Dosage Forms
- IMPLANT
- Routes
- INTRAMUSCULAR
- Active Ingredients
- ALLOGENEIC THYMOCYTE-DEPLETED THYMUS TISSUE-AGDC
Indications and Usage
1 INDICATIONS AND USAGE RETHYMIC ® is indicated for immune reconstitution in pediatric patients with congenital athymia. RETHYMIC is indicated for immune reconstitution in pediatric patients with congenital athymia. ( 1 ) Limitations of Use : RETHYMIC is not indicated for the treatment of patients with severe combined immunodeficiency (SCID). Limitations of Use RETHYMIC is not indicated for the treatment of patients with severe combined immunodeficiency (SCID).